These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9288839)

  • 1. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
    Horiot JC; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg AC; Pierart M; Collette L
    Radiother Oncol; 1997 Aug; 44(2):111-21. PubMed ID: 9288839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Controlled clinical trials of hyperfractionated and accelerated radiotherapy in otorhinolaryngologic cancers].
    Horiot JC
    Bull Acad Natl Med; 1998; 182(6):1247-60; discussion 1261. PubMed ID: 9812410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
    Poulsen MG; Denham JW; Peters LJ; Lamb DS; Spry NA; Hindley A; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
    Radiother Oncol; 2001 Aug; 60(2):113-22. PubMed ID: 11439206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma--the ARTSCAN study.
    Zackrisson B; Nilsson P; Kjellén E; Johansson KA; Modig H; Brun E; Nyman J; Friesland S; Reizenstein J; Sjödin H; Ekberg L; Lödén B; Mercke C; Fernberg JO; Franzén L; Ask A; Persson E; Wickart-Johansson G; Lewin F; Wittgren L; Björ O; Björk-Eriksson T
    Radiother Oncol; 2011 Jul; 100(1):41-8. PubMed ID: 21295880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of accelerated fractionation radiotherapy with and without mitomycin C in the treatment of locally advanced head and neck cancer.
    Ezzat M; Shouman T; Zaza K; Safwat A; El-Khoudary A; El-Senosi M; Ezzat I
    J Egypt Natl Canc Inst; 2005 Jun; 17(2):85-92. PubMed ID: 16508679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study.
    Poulsen M; Denham J; Spry N; Lamb D; Peters L; Krawitz H; Penniment M; Williamson S; Tripcony L
    Australas Radiol; 1999 Nov; 43(4):487-94. PubMed ID: 10901965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
    Dobrowsky W; Naudé J
    Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.
    Dische S; Saunders M; Barrett A; Harvey A; Gibson D; Parmar M
    Radiother Oncol; 1997 Aug; 44(2):123-36. PubMed ID: 9288840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
    Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
    Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized trial to compare accelerated (six fractions a week) radiotherapy against concurrent chemoradiotherapy (using conventional fractionation) in locally advanced head and neck cancers.
    Gupta M; Mahajan R; Kaushal V; Seem RK; Gupta M; Bhattacharyya T
    J Cancer Res Ther; 2015; 11(4):723-9. PubMed ID: 26881508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
    Bernier J; Denekamp J; Rojas A; Minatel E; Horiot J; Hamers H; Antognoni P; Dahl O; Richaud P; van Glabbeke M; Piérart M
    Radiother Oncol; 2000 May; 55(2):111-9. PubMed ID: 10799722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.
    Lee DJ; Cosmatos D; Marcial VA; Fu KK; Rotman M; Cooper JS; Ortiz HG; Beitler JJ; Abrams RA; Curran WJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):567-76. PubMed ID: 7790241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.
    Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S
    Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma.
    Hassan Metwally MA; Ali R; Kuddu M; Shouman T; Strojan P; Iqbal K; Prasad R; Grau C; Overgaard J
    Radiother Oncol; 2015 Jul; 116(1):15-20. PubMed ID: 25913070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer.
    Leborgne F; Zubizarreta E; Fowler J; Ortega B; Mezzera J; Deus JL; Leborgne JH
    Int J Cancer; 2000 Apr; 90(2):80-91. PubMed ID: 10814958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
    Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
    Zackrisson B; Kjellén E; Söderström K; Brun E; Nyman J; Friesland S; Reizenstein J; Sjödin H; Ekberg L; Lödén B; Franzén L; Ask A; Wickart-Johansson G; Lewin F; Björk-Eriksson T; Lundin E; Dalianis T; Wennerberg J; Johansson KA; Nilsson P
    Radiother Oncol; 2015 Oct; 117(1):99-105. PubMed ID: 26427805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer.
    Cummings B; Keane T; Pintilie M; Warde P; Waldron J; Payne D; Liu FF; Bissett R; McLean M; Gullane P; O'Sullivan B
    Radiother Oncol; 2007 Oct; 85(1):7-16. PubMed ID: 17920715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
    Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
    Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.